First Analysis
http://www.firstanalysis.com/index.asp?PID=16First Analysis is an investment organization specializing in private equity, venture capital, investment banking, and equity research. The sectors in the firm’s coverage universe include outsourced services, IT products and services, and chemistry-enabled businesses. First Analysis was founded in 1981.
View Older Stories View More Recent Stories
-
First Analysis Upgrades K12, Inc. (LRN) to Overweight
-
U.S., Australia, Canada indigenous land rights laws lag Africa, Latam: mapping study
-
NYU, Google Researchers Hack the Business Model of Adware, Scareware, and Other Unwanted Software
-
It's "Startup Day": The U.S. Needs More Entrepreneurs
-
NYU, Google Researchers Hack the Business Model of Adware, Scareware, and Other Unwanted Software
-
First Analysis Upgrades Total System Services (TSS) to Overweight
-
New Studies Suggest Relationship between Tau Pathology and Progression of Alzheimer's Disease
-
First Analysis Downgrades HealthStream (HSTM) to Equal Weight
-
First Analysis Downgrades Paylocity Holding (PCTY) to Equal Weight
-
First Analysis Starts Alarm.com (ALRM) at Overweight
-
Ted Iacobuzio, payments industry veteran, joins Mercator Advisory Group
-
First Analysis Downgrades Insperity (NSP) to Equal Weight
-
Notable Analyst Rating Changes 7/1: (GSK) (WRI) (GEL) Upgraded; (CVRR) (SWKS) (AVY) Downgraded
-
First Analysis Starts Cornerstone OnDemand (CSOD) at Overweight
-
First Analysis Starts Bottomline Technologies (EPAY) at Overweight
-
StreamLink Software Raises $10 Million Round Led by First Analysis
-
First Analysis Downgrades LinkedIn (LNKD) to Equal Weight
-
AlloSure™ Shows Promise to Detect Rejection in Transplant Patients with a Simple Blood Test
-
AstraZeneca Presents Findings from Two Pooled Analyses at the 76th Scientific Sessions of the American Diabetes Association Evaluating Dapagliflozin in Type 2 Diabetes Patients with Renal Impairment a
-
NantHealth Announces Closing of Initial Public Offering
-
AbbVie (ABBV) Announces Additional Data on IMBRUVICA Phase 3 in CLL/SLL
-
AbbVie Builds Upon Robust Body of IMBRUVICA® (ibrutinib) Data with Phase 3 Longer-Term Studies in Patients with Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Presented at the American S
-
CareDx to Host Call to Provide First Analysis of Data from DART Study
-
New Data Reveal That Presence of Metastases at Initial Prostate Cancer Diagnosis May Have a Critical Impact on Prognosis for Metastatic Castration-Resistant Patients
-
NantHealth (NH) IPO Opens 15%
-
NantHealth (NH) Prices 6.5M Common Stock IPO at $14/Share, Inline with Expectations
-
NantHealth Announces Pricing of Initial Public Offering
-
AREVA: Quality Audit at the Le Creusot Plant: End of May Status Update
-
Apixio Closes $19.3 Million in Series D Funding; Continues to Fuel Healthcare Transformation With Cognitive Computing Platform
-
New Accenture White Paper Reveals True Cost of Title Insurance Production from Title Industry Benchmark Study
-
GSK Present New Data From Breo(R) Ellipta(R) SUMMIT Study in Patients With COPD at ATS Conference
-
Immune Design Reports First Quarter 2016 Financial Results and Provides Corporate Update
-
NantHealth Files Registration Statement for Proposed Initial Public Offering
-
First Analysis Downgrades MiMedx Group (MDXG) to Equal Weight
-
The Southwest Effect Makes its Way Into International Markets
-
First Analysis Starts Pacific Biosciences of California (PACB) at Overweight
-
Intercept Pharma (ICPT) Announces Presentation of Positive Ocaliva Phase 3 Data in PBC
-
New Analyses of the Phase 3 POISE Trial of Ocaliva™ (Obeticholic Acid) for the Treatment of PBC Presented at EASL
-
AuthenticID Wins All Payments Expo Shark Tank with Its Groundbreaking CatfishAIR Identity Verification Solution for Financial Services Providers
-
First Analysis Starts Aceto Corp. (ACET) at Overweight
-
Post-Traumatic Stress Disorder Seen in Many Adults Living with Congenital Heart Disease
-
NimbeLink Secures $2.5 Million in Financing From First Analysis
-
First Analysis Upgrades CBIZ, Inc. (CBZ) to Equal Weight
-
EU competition watchdog to release initial findings on cross-border e-commerce
-
Zillow Reveals Best Window to Sell Homes Faster and for the Highest Price; Launches Best Time to List Tool for Sellers
-
First Analysis Starts Q2 Holdings (QTWO) at Overweight
-
Two Quality of Life (QoL) Interim Analyses Presented at ASCO Quality Care Symposium Represent First Results from ABOUND ABRAXANE® Lung Cancer Program
-
Cartasite Announces New Equity Investment
-
First Analysis Upgrades Insperity (NSP) to Overweight
-
Hireology Reports Accelerated Growth and Market Traction

